Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04177615

Acronym

RARETBAS

Enrollment

109

Registered

2019-11-26

Start date

2019-11-19

Completion date

2020-12-30

Last updated

2019-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basilar Artery Occlusion, Stroke, Acute

Keywords

Ischemic stroke, Basilar Artery Occlusion

Brief summary

This is a prospective, open lable studies conducted in 115 hospital to compare between thromboectomy and Recombinant Tisue Plasminogen Activator only to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients

Detailed description

Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar artery occlusion are not known. Although basilar artery occlusion has been reported in 2 per 1000 autopsy cases, basilar artery thrombosis may, in stroke registries, explain as many as 27% of ischemic strokes occurring in the posterior circulation.Various treatments were tried in groups of patients with vertebrobasilar territory infarction but evidence based was not cleared previous studies. Therefore, we conduct this study to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients

Interventions

PROCEDUREThromboectomy

Thromboectomy in Basilar Artery Occlusion patients

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients admit to 115 hospital in 24h of Basilar Artery Occlusion Stroke * NIHSS \> 4 points

Exclusion criteria

* Patients refuse to participate in studies * Patients with contraindication of either rTPA or thromboectomy

Design outcomes

Primary

Measure	Time frame	Description
NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission	24 hours from admission	NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission
Survival rate in patients with Basilar Artery Occlusion Stroke	3 months from admission	Survival rate in patients with Basilar Artery Occlusion Stroke

Secondary

Measure	Time frame	Description
mRS in patients with Basilar Artery Occlusion Stroke	3 months from admission	mRS in patients with Basilar Artery Occlusion Stroke

Contacts

Primary ContactDUNG U Tran Nguyen

uyendungtrannguyen@gmail.com0902610832

Backup ContactTHANG H Nguyen, MD, PhD

033962478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026